The Great Retail Price Divide
This collection of stocks represents retailers capitalizing on Amazon's price increases by offering better deals on everyday essentials. These companies were carefully selected by our analysts for their potential to attract budget-conscious shoppers looking for more affordable alternatives.
Your Basket's Financial Footprint
Market capitalisation breakdown for the basket 'The Great Retail Price Divide' with total market cap and constituents.
- Large-cap dominance generally implies lower volatility and closer tracking to broad market performance, reducing idiosyncratic risk.
- Suitable as a core holding in a diversified portfolio, not as a high-conviction speculative position.
- Likely to deliver steady long-term value rather than rapid, short-term explosive gains.
WMT: $846.88B
COST: $415.48B
TGT: $42.90B
- Other
About This Group of Stocks
Our Expert Thinking
As Amazon raises prices on essential goods by an average of 5%, discount retailers are strategically positioning themselves to capture price-sensitive consumers. This represents a significant shift in retail dynamics, where value-focused companies can potentially gain market share from higher-priced competitors.
What You Need to Know
This collection focuses on discount retailers, off-price apparel stores, and warehouse clubs with business models centered on providing value. These companies are directly benefiting from consumers actively seeking relief from inflation through more affordable shopping alternatives.
Why These Stocks
Each company in this group was selected for its strong value proposition and potential to absorb market share from higher-priced competitors. These retailers are tactically positioned to capitalize on changing consumer loyalty and spending habits driven by the current competitive pricing environment.
Why You'll Want to Watch These Stocks
The Consumer Loyalty Shift
Amazon's 5% price hike on essentials is creating a rare opportunity for competitors to win over price-conscious shoppers. These retailers are perfectly positioned to capture this migration of budget-focused customers.
Hidden Value Opportunity
While headlines focus on Amazon, these companies are quietly gaining ground by offering better deals on everyday items. Many investors haven't connected these dots yet, giving you a chance to get in early.
Inflation-Beating Potential
As consumers battle rising prices, these retailers offer genuine savings opportunities that are becoming increasingly attractive. Their business models are specifically designed to thrive when shoppers prioritize value above all else.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Global Infrastructure Partners: UAE Exposure Risks
The UAE's strategic push for economic diversification and smart city development is creating significant demand for advanced construction and infrastructure solutions. This basket provides exposure to a selection of US and EU-listed companies that supply essential materials, technology, and engineering services to the region's projects.
UAE Infrastructure Global Suppliers Breakdown
As the UAE continues its ambitious economic diversification, demand for world-class infrastructure creates opportunities for the companies that build it. This basket offers exposure to US and EU-listed industrial, materials, and technology firms that are integral to developing these large-scale projects.
Antiviral M&A Wave: Biotech Opportunities in 2025
Merck's $9.2 billion acquisition of Cidara Therapeutics strengthens its antiviral pipeline as a key patent nears expiry. This major deal signals a growing trend of pharmaceutical giants buying smaller biotechs, creating potential opportunities among companies with promising infectious disease therapies.